Baraclude treats hepatitis B infection. This medication may cause a build-up of acid in the blood.

Now Playing
Pharmacist Steve Lozano, PharmD summarizes the uses, common side effects, and warnings for the NRTIs class of medications
Next Video
Pharmacist Steve Lozano, PharmD summarizes the uses, common side effects, and warnings for the NRTIs class of medications
Pharmacist Steve Lozano, PharmD summarizes the uses, common side effects, and warnings for the Antivirals class of medications

Baraclude Overview


Baraclude is a prescription medicine used to treat chronic (long term) hepatitis B virus (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have active liver damage. 

Baraclude belongs to a group of drugs called nucleoside analogs. It works by decreasing the amount of virus in the body.

This medication comes in tablet form and a solution (liquid) which is taken by mouth, once daily, on an empty stomach. 
Common side effects are headache, tiredness, dizziness, and nausea.

Patient Ratings for Baraclude

How was your experience with Baraclude?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking Baraclude?

What are you taking Baraclude for?

Choose one
  • Other
  • Hepatitis B

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did Baraclude work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend Baraclude to a friend?

Pill Images

{{ }}
pill-image {{ }}
Color: {{ slide.color }} Shape: {{ slide.shape }} Size: {{ slide.size }} Score: {{ slide.score }} Imprint: {{ slide.imprint }}
{{ slide.number }} of {{ }}

Baraclude Cautionary Labels


Uses of Baraclude

Baraclude is a prescription medicine used to treat chronic (long-term) hepatitis B virus (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have active liver damage.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.


Baraclude Drug Class

Side Effects of Baraclude

Baraclude may cause serious side effects. See “Drug Precautions”.

The most common side effects of Baraclude include:

  • headache
  • tiredness
  • dizziness
  • nausea

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Baraclude. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Baraclude Interactions

Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist when you get a new medicine.

Baraclude Precautions

Your hepatitis B virus infection may get worse if you stop taking Baraclude. This usually happens within 6 months after stopping Baraclude.

  • Take Baraclude exactly as prescribed.
  • Do not run out of Baraclude.
  • Do not stop Baraclude without talking to your healthcare provider.
  • Your healthcare provider should monitor your health and do regular blood tests to check your liver if you stop taking Baraclude.

If you have or get HIV that is not being treated with medicines while taking Baraclude, the HIV virus may develop resistance to certain HIV medicines and become harder to treat. You should get an HIV test before you start taking Baraclude and anytime after that when there is a chance you were exposed to HIV.

Baraclude can cause serious side effects including lactic acidosis and serious liver problems.

Lactic acidosis (buildup of acid in the blood). Some people who have taken Baraclude or medicines like Baraclude (a nucleoside analogue) have developed a serious condition called lactic acidosis. Lactic acidosis is a serious medical emergency that can cause death. Lactic acidosis must be treated in the hospital. Reports of lactic acidosis with Baraclude generally involved patients who were seriously ill due to their liver disease or other medical condition.

Call your healthcare provider right away if you get any of the following signs or symptoms of lactic acidosis:

  • You feel very weak or tired.
  • You have unusual (not normal) muscle pain.
  • You have trouble breathing.
  • You have stomach pain with nausea and vomiting.
  • You feel cold, especially in your arms and legs.
  • You feel dizzy or light-headed.
  • You have a fast or irregular heartbeat.

Serious liver problems. Some people who have taken medicines like Baraclude have developed serious liver problems called hepatotoxicity, with liver enlargement (hepatomegaly) and fat in the liver (steatosis). Hepatomegaly with steatosis is a serious medical emergency that can cause death.

Call your healthcare provider right away if you get any of the following signs or symptoms of liver problems:

  • Your skin or the white part of your eyes turns yellow (jaundice).
  • Your urine turns dark.
  • Your bowel movements (stools) turn light in color.
  • You don’t feel like eating food for several days or longer.
  • You feel sick to your stomach (nausea).
  • You have lower stomach pain.

You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight, or have been taking nucleoside analogue medicines, like Baraclude, for a long time.

Baraclude Food Interactions

Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Baraclude there are no specific foods that you must exclude from your diet when receiving this medication.


Inform MD

Before you take Baraclude , tell your healthcare provider if you:

  • have kidney problems. Your Baraclude dose or schedule may need to be changed.
  • have received medicine for HBV before. Some people, especially those who have already been treated with certain other medicines for HBV infection, may develop resistance to Baraclude. These people may have less benefit from treatment with Baraclude and may have worsening of hepatitis after resistant virus appears. Your healthcare provider will test the level of the hepatitis B virus in your blood regularly.
  • have any other medical conditions.
  • are pregnant or breastfeeding

Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Baraclude and Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Baraclude falls into category C. There are no well-done studies that have been done in humans with Baraclude. But in animal studies, pregnant animals were given this medication, and the babies did not show any medical issues related to this medication.

  • Pregnancy Registry. If you take Baraclude  while you are pregnant, talk to your healthcare provider about how you can take part in the Pregnancy Registry. The purpose of the pregnancy registry is to collect information about the health of you and your baby.

Baraclude and Lactation

Tell your healthcare provider if you are breastfeeding or plan to breastfeed.

It is not known if Baraclude crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Baraclude.



Baraclude Usage

  • Take Baraclude exactly as your healthcare provider tells you to.
  • Your healthcare provider will tell you how much Baraclude to take.
  • Your healthcare provider will tell you when and how often to take Baraclude.
  • Take Baraclude on an empty stomach, at least 2 hours after a meal and at least 2 hours before the next meal.
  • If you are taking Baraclude oral solution, carefully measure your dose with the spoon provided, as follows:
    • Hold the spoon in a vertical (upright) position and fill it gradually to the mark corresponding to the prescribed dose. Holding the spoon with the volume marks facing you, check that it has been filled to the proper mark.
    • Swallow the medicine directly from the measuring spoon.
    • After each use, rinse the spoon with water and allow it to air dry.
    • If you lose the spoon, call your pharmacist or healthcare provider for instructions.
  • Do not change your dose or stop taking Baraclude without talking to your healthcare provider.
  • If you forget to take Baraclude, take it as soon as you remember and then take your next dose at its regular time. If it is almost time for your next dose, skip the missed dose. Do not take two doses at the same time. Call your healthcare provider or pharmacist if you are not sure what to do.
  • When your supply of Baraclude starts to run low, call your healthcare provider or pharmacy for a refill. Do not run out of Baraclude.

Baraclude Dosage

Compensated Liver Disease

The recommended dose of Baraclude for chronic hepatitis B virus infection in nucleoside-treatment-naïve adults and adolescents 16 years of age and older is 0.5 mg once daily.

The recommended dose of Baraclude in adults and adolescents (at least 16 years of age) with a history of hepatitis B viremia while receiving lamivudine or known lamivudine or telbivudine resistance mutations rtM204I/V with or without rtL180M, rtL80I/V, or rtV173L is 1 mg once daily.

Decompensated Liver Disease

The recommended dose of Baraclude for chronic hepatitis B virus infection in adults with decompensated liver disease is 1 mg once daily.

Baraclude (Baraclude) Oral Solution contains 0.05 mg of Baraclude per milliliter. Therefore, 10 mL of the oral solution provides a 0.5 mg dose and 20 mL provides a 1 mg dose of Baraclude.

Kidney Disease

The recommended dose may be reduced if kidney function is impaired.

Dosage in Children

The recommended dose for children is based on weight and prior treatment.


Baraclude Overdose

If you take too much Baraclude, call your healthcare provider or go to the nearest emergency room right away.


Other Requirements

  • Store Baraclude tablets or oral solution at room temperature, between 59° F to 86° F (15° C to 30° C).
  • Keep Baraclude tablets in a tightly closed container.
  • Do not store Baraclude tablets in a damp place such as a bathroom medicine cabinet or near the kitchen sink.
  • Store Baraclude oral solution in the original carton, and keep Baraclude oral solution out of the light.
  • Safely throw away Baraclude that is out of date or no longer needed. Dispose of unused medicines through community take-back disposal programs when available or place Baraclude in an unrecognizable closed container in the household trash.

Keep Baraclude and all medicines out of the reach of children.

Baraclude FDA Warning


Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including Baraclude. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted.

Limited clinical experience suggests there is a potential for the development of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitors if Baraclude is used to treat chronic hepatitis B virus (HBV) infection in patients with HIV infection that is not being treated. Therapy with Baraclude is not recommended for HIV/HBV co-infected patients who are not also receiving highly active antiretroviral therapy (HAART).

Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination with antiretrovirals.